Skip to main content
What We Do: A Letter To Investors From Cathie Wood Read Now

Looking For Our European Funds?

Click Here
About How To Invest
ARK Invest logo
You Are Entering

Please read this page before proceeding, as it explains certain restrictions imposed by law on the distribution of this information and the countries in which the funds are authorized for sale. By proceeding, you are confirming you understand that ARK Investment Management LLC or its affiliates (collectively, “ARK”), makes no representation that the content of the website is appropriate for use in all locations, or that the transactions, securities, products, instruments or services discussed at this website are available or appropriate for sale or use in all jurisdictions or countries, or by all investors or counterparties.

This section of the website is operated by ARK, and is only directed at U.S. investors or those otherwise authorized to conduct investment business in the U.S. Persons resident in territories other than the United States should not access this website.

It is your responsibility to be aware of and to observe all applicable laws and regulations of any relevant jurisdiction. Certain of the funds and advisory products and services referenced on this website may be managed or offered/provided by affiliates of ARK. Additionally, certain of the funds described in the following pages may be marketed in certain jurisdictions only. Any entity forwarding the material or information contained on this website, which is produced by ARK in the United States, to other parties takes full responsibility for ensuring compliance with applicable securities laws in connection with its distribution.

This website only includes information on those funds that are registered for sale in the United States.

By accessing this website, you are confirming that you agree to the Terms and Conditions of this website and that you are resident in the United States or those otherwise authorized to conduct investment business in the U.S.

The contents of this website have been prepared for informational purposes only without regard to the investment objectives, financial situation, or means of any particular person or entity, and ARK is not soliciting any action based upon them. No information included on this website is to be construed as investment advice or as a recommendation or a representation about the suitability or appropriateness of any fund; or an offer to buy or sell, or the solicitation of an offer to buy or sell, any security, financial product, or instrument; or to participate in any particular trading strategy. ARK recommends that you seek independent financial and tax advice before making any investment decisions. Investment in any of the funds described in this website should only be made on the basis of the terms and conditions of the most recent applicable offering documents (including any relevant supplements).

All material has been obtained from sources believed to be reliable, but its accuracy is not guaranteed. Some of the content on this website may contain certain statements that may be deemed forward-looking statements. Please note that any such statements are not guarantees of any future performance and actual results or developments may differ materially from those projected. From time to time, ARK may also make additional features available to users on this website on such terms and conditions as may be set forth in a modification to this Agreement or otherwise on the ARK website.

The ARK ETF Trust Thematic Actively Managed ETF’s are distributed by Foreside Fund Services, LLC (“Foreside“), which is not affiliated with ARK Investment Management LLC. Check the background of Foreside on FINRA’s BrokerCheck.

You should carefully consider the investment objective, risks, charges and expenses of a Fund before investing. A Fund’s prospectus and summary prospectus contain this and other important information about a Fund, which can be obtained by clicking the corresponding link or dialing the indicated phone number herein. Please read the appropriate prospectus carefully before investing.


You should be aware that past performance is not a reliable indicator of future performance. Please note that the price of units or shares and the income from them can fall as well as rise and you may not get back the amount originally invested. Income receivable may vary from the amount of income projected at the time of making the investment.

Exchange rate fluctuations may affect the value of an investment and any income derived from it.

If you exercise any right to redeem, you may not get back the amount initially invested if the unit or share price has fallen since you invested. Deductions for charges and expenses, particularly the initial charge (if any), are not made uniformly throughout the life of the investment, so if you redeem out of the investment during the early years, you may not get back the amount invested.

There can be no guarantee that the tax position or proposed tax position prevailing at the time of an investment will not change. Dividends and capital gains on securities issued in the relevant funds may be subject to withholding taxes imposed by the countries in which each particular fund invests.

The offering documents for the investment funds contain important information summarizing the relevant risk factors pertaining to the investment or relevant funds. Please note, however, that no summary of risk factors is exhaustive, and there may be other risks that could affect your investment. For your own benefit and protection you should read the most recent offering documents (including any relevant supplements) carefully before investing. If you do not understand any point please ask for further information.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation, or which would subject any of the funds described herein, ARK (including its affiliates) or any of their products or services to any registration, licensing or other authorization requirement within such jurisdiction or country. Nothing on this website shall be considered a solicitation to buy or sell a security, product or service (including advisory service) to any person.


ARK does not recommend or endorse and accepts no responsibility for the content of any website not operated by ARK which you may visit by following a link from this website. You acknowledge and agree that neither ARK nor any of its affiliates is responsible for the availability of such third-party websites or resources, does not endorse, approve, investigate or verify, and is not responsible or liable for any content, advertising, products, or other materials on or available from such websites or resources. You further agree that neither ARK nor any of its affiliates shall be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with use of or reliance on any such content, products or services available on such external websites or resources. These links are provided as a convenience and solely for informational purposes. ARK is not making any recommendation to invest in, purchase, or sell any securities or other products or services offered on the linked websites, nor has ARK sought to verify or confirm the information contained in the linked websites. Accordingly, ARK disclaims any responsibility for the linked websites.

No other website, without the prior written permission of ARK, is authorized to link to any part of this website.


ARK uses cookies for collecting user information from certain pages of this website. A cookie is a file that is stored on the hard disk of a computer by the web browser on a computer. It contains information sent by the website that a user has visited. A cookie identifies users and can store information about them and their use of a website. ARK uses cookies to keep track of user activity, which allows ARK to identify which areas of the website are more interesting to the users so that improvements can be made to this website.

ARK expressly reserves the right to monitor any use of this website.

I confirm that I have read and accept the Terms and Conditions of using this website and that I am based in the United States or those otherwise authorized to conduct investment business in the United States.

Q1 2022: Commentary From ARK’s CIO

April 19, 2022 | ETF

By ARK Invest

Broad-based global equity indexes[1] depreciated significantly during the first quarter as macro headwinds hurt consumer, business, and investor confidence. Innovation stocks, particularly those not listed on broad-based indexes, were punished disproportionately in response to investor fears of higher inflation and interest rates. Dominating most broad-based indexes, in our opinion, several mega-cap stocks have lured risk-averse investors into crowded trades that appear to be missing many emerging growth opportunities in the disruptive innovation space. Contrary to mainstream view, we believe this dynamic has pushed innovation stocks into deep value territory.

While public equities in what we view as the pure-play innovation space have collapsed during the past year, late-stage private market valuations have soared. Based on our analysis, the median value of late-stage startups announcing new funding rounds in February has soared roughly 180% in the median of 260 days since their prior funding rounds. At the same time, the MSCI IMI Innovation Index has depreciated by 14%. Conversely, some company valuations inflated by excess capital in the private equity market now are experiencing down rounds, in our view, because they have not focused on truly disruptive innovation. In other words, valuations associated with pure play innovation companies in the public and private markets are at odds. We believe that the truth is somewhere in between the two, signaling potential upside to valuations in the public equity markets.

Between March 2021 and the end of the first quarter, the yield curve[2] flattened from 159 basis points to 4 basis points and then inverted one day later, suggesting that if the Federal Reserve raises interest rates, then real growth, inflation, or both will surprise on the low side of expectations. US consumer sentiment[3] is lower today than it was at the depths of the coronavirus pandemic and has dropped to levels last seen during both the 2008-2009 Global Financial Crisis and the early 1980s when inflation and interest rates hit double digits. With the exception of the 2011 European Debt Crisis, this level of consumer sentiment levels has coincided with periods before or during recessions.

The odds of a recession appear to have increased meaningfully after Russia’s invasion of Ukraine. Although inflationary in the short-term, the rise in oil prices has imposed a highly regressive tax on consumers. Highly dependent on Russia for energy, Europe probably has entered recession, while China seems to have erred on the side of restraint and is trying to resuscitate growth.

In our view, long-term inflation fears have been overblown because inventories have begun to pile up in the face of weak consumption. During the fourth quarter, real GDP increased 6.9%, 532 basis points of which was attributable to inventory growth. At the same time, the consumer savings rate dropped to 6.3%, roughly 200 basis points below its pre-coronavirus crisis, suggesting less room for future consumption. As a result, retail sales growth has been lower than inflation. While government stimulus was flowing freely, businesses and consumers seem to have overreacted to supply chain bottlenecks by building “inventories” of goods. In the short term, along with other geopolitical forces, this hoarding has pushed US consumer price inflation to 8.6% on a year-over-year basis, a rate that we believe deflationary forces––good, bad, and cyclical––are likely to unwind during the next year.

Innovation is the source of good deflation, as learning curves cut costs and increase productivity. Yet, we believe many companies have catered to the short-term-oriented, risk-averse shareholders and have satisfied demands for profits/dividends “now”. As a result, many have leveraged their balance sheets to buy back stock, bolster earnings, and increase dividends. In so doing, many have curtailed investments in innovation and could be ill-prepared for the impact of disintermediation associated with disruptive innovation. As a result, saddled with aging products and services, they could be forced to cut prices, service debt, and clear unwanted inventories, causing bad deflation.

If we are correct in our assessment that growth, inflation, or both are likely to surprise on the downside, scarce double-digit growth opportunities will be rewarded accordingly. The onset of the pandemic and subsequent variants generated broad-based fear, uncertainty, and doubt (FUD) in the equity markets, causing what we believe to be indiscriminate, algorithmic selling as a form of short-term risk management. Typically, FUD accelerates the adoption of new technologies as concerned businesses and consumers change their behavior much more rapidly, causing new leadership to surface in the equity market. We believe the coronavirus crisis and the Russian invasion of Ukraine have transformed the world significantly and permanently, suggesting that many innovation-driven stocks could be productive holdings during the next five to ten years.

In our view, the wall of worry built on the back of high multiple stocks bodes well for equities in the innovation space. The strongest bull markets do climb a wall of worry, a fact that those making comparisons to the tech and telecom bubble seem to forget. No wall of worry existed or tested the equity market in 1999. This time around, the wall of worry has scaled to enormous heights.

Investors in broad-based equity indexes seem to be shorting innovation, perhaps inadvertently and, if history is any guide, we believe it will be to their detriment. Amazon invested aggressively to disrupt legacy brick and mortar businesses, for example, and captured a disproportionate share of the retail e-commerce opportunity as most investors assumed it would go bankrupt. Wall Street also missed the potential of Apple’s iPhone to disrupt Nokia, Samsung, and Blackberry, and in the last five years denigrated Bitcoin and cryptoassets as Ponzi schemes. For many years, traditional auto analysts doomed Tesla to failure without understanding that it was a robotics, energy storage, and artificial intelligence company, not an auto company. Controversial and volatile in the short-term, companies focused on innovation that solves problems and disrupts legacy industries can, in some instances, surprise with significant growth.

During the first quarter of 2022, ARK’s six actively managed ETFs and three indexed ETFs mostly underperformed relative to the S&P 500 Index and the MSCI World Index, though one of our actively managed ETFs outperformed the MSCI World Index.

ARK Autonomous Technology and Robotics ETF (ARKQ)

The ARK Autonomous Technology and Robotics ETF (ARKQ) the quarter. UiPath (PATH) and Tusimple (TSP) were the top detractors. Shares of UiPath fell after the company reported fourth-quarter earnings that beat Wall Street expectations on revenue and non-GAAP EPS but cut forward guidance based on its outsized exposure to Europe. We maintain high conviction in UiPath’s ability to integrate Robotic Process Automation (RPA) into many business processes across large enterprises around the world. TSP traded down following the company’s announcement that CTO Xiaodi Hou, one of the two founders of this autonomous trucking company, will replace CEO Cheng Lu. We are confident in Xiaodi’s ability to execute on TuSimple’s autonomous strategy. TuSimple’s autonomous semi-truck test in January resulted in positive research analyst reviews.

Among the top contributors to ARKQ’s performance were AeroVironment (AVAV) and Deere & Company (DE). Shares of AeroVironment rallied sharply after Russia’s invasion of Ukraine and the Biden Administration’s announcement that it would consider providing Ukraine and European allies with AeroVironment’s Switchblade drones. Because Ukraine is one of Europe’s largest food suppliers, the war has increased food prices and farm profits, which should encourage investment in newer, more efficient farming machinery. Deere also disclosed that its fully autonomous tractor would be available for farmers this year.

ARK Next Generation Internet ETF (ARKW)

The ARK Next Generation Internet ETF (ARKW) underperformed the broad-based market indexes during the quarter. Among the top detractors were Roku (ROKU) and Shopify (SHOP). Shares of Roku gapped down after the company reported lower than expected fourth-quarter revenue growth and guided for further deceleration. Management cited supply chain bottlenecks and inventory shortages that have impacted its OEM smart TV partners. Management also noted that active accounts increased to more than 60 million, surpassing the number of video subscribers at all US cable companies combined. Although US consumers spend 45% of their viewing hours on streaming TV today, streaming TV advertising accounts for only 18% of total TV advertising budgets, a gap we expect to close. Shares of Shopify traded down after the company reported not only a deceleration in gross merchandise value growth for the fourth quarter but also softer than expected guidance and an increase in investment spend for 2022. We believe Shopify is positioned uniquely as an operating system enabling merchants to sell direct-to-consumer across marketplaces and social media platforms.

Among the top contributors to ARKW’s performance were Tesla (TSLA) and Splunk (SPLK). Shares of Tesla finished marginally higher after a quarter of positive fundamental developments, including a fourth-quarter earnings report that beat on both the top- and bottom-lines. The shift from gas-powered to electric vehicles has gained traction, a trend that we believe higher gas prices following Russia’s invasion of Ukraine will accelerate. Tesla also opened its fourth Gigafactory in Berlin, which should help satisfy growing demand. Hertz added the Model 3 to its rental fleet last year and announced in March that it plans to add the Model Y. Shares of Splunk responded positively to BTIG’s upgrade after a selloff related to significant management transitions.

ARK Genomic Revolution ETF (ARKG)

The ARK Genomic Revolution ETF (ARKG) underperformed the broad-based market indexes during the quarter. Among the top detractors were Pacific Biosciences of California (PACB) and Intellia Therapeutics (NTLA). Shares of Pacific Biosciences depreciated during a challenging quarter for genomics-focused companies that was exacerbated by its weaker-than-expected 2022 revenue guidance. Management noted that Omicron caused widespread lab closures on the east coast in the US and in Europe during January, hurting the utilization of consumables. In our view, investors underappreciate the importance of HiFi sequencing, which sequenced the first full human genome in 2021. We also believe fears of competition from synthetic long-read sequencing are unfounded. Intellia released data demonstrating the efficacy of its gene-editing therapy for the treatment of transthyretin-related hereditary amyloidosis (hATTR). A 93% reduction in the concentration of the mutant protein among the trial subjects was an improvement over existing hATTR therapies but the stock “sold off on the news”. During the quarter, Intellia also acquired Rewrite Therapeutics, a biotech company focused on advancing novel DNA writing technologies.

Among the top contributors to ARKG’s performance were Ionis Pharmaceuticals (IONS) and Signify Health (SGFY). Ionis and Biogen terminated their amyotrophic lateral sclerosis (ALS) treatment but committed to continued research on the disease. Signify Health beat revenue expectations for the fourth quarter and guided first quarter revenues higher than consensus estimates. At the JP Morgan Healthcare conference in January, management provided updates on the company’s transition-to-home service, which included more than a 10% reduction in readmission rates relative to the industry status quo.

ARK Fintech Innovation ETF (ARKF)

The ARK Fintech Innovation ETF (ARKF) underperformed the broad-based market indexes during the quarter. Among the top detractors were Shopify (SHOP) and UiPath (PATH), for reasons discussed above.

Among the top contributors to ARKF’s performance were Discovery Limited (DSY SJ) and Silvergate Capital (SI). Shares of Discovery traded up alongside other insurance-focused businesses that fared relatively well in a market highly sensitized to the risks associated with higher interest rates and inflation. Discovery uses the convergence of artificial intelligence and behavioral science to underwrite its insurance and digital banking ecosystems. Shares of Silvergate Capital dropped after the company reported lower than expected margins in its fourth quarter earnings report. Notably, however, the company reported a 35% sequential increase in transfer volumes on the Silvergate Exchange Network (SEN), bolstering our confidence that it is and will remain a prime beneficiary of increased institutional crypto adoption. President Joe Biden’s much-anticipated Executive Order on digital assets suggested a net-positive regulatory outlook for crypto and sparked a rally in shares of Silvergate. The Order outlines a “whole-of-government” approach to crypto and underscores the importance of US leadership in technological innovation.

ARK Space Exploration & Innovation ETF (ARKX)

The ARK Space Exploration & Innovation ETF (ARKX) had mixed performance relative to broad-based market indexes during the quarter, underperforming the S&P 500 Index but outperforming the MSCI World Index. Among the top detractors were UiPath (PATH) and Trimble (TRMB). Shares of UiPath detracted from performance for reasons discussed above. Trimble, a leader in advanced global positioning solutions with a focus on autonomous technology, reported better than expected fourth-quarter revenue but missed earnings expectations, citing supply chain backlogs.

Among the top contributors to ARKX’s performance were AeroVironment (AVAV) and L3Harris Technologies (LHX). Shares of AeroVironment appreciated for reasons discussed above. Shares of L3Harris Technologies rallied following Russia’s invasion of Ukraine, bolstering the outlook for defense spending by the US and Europe.

ARK Innovation ETF (ARKK)

With some of the highest conviction names from the Funds discussed above, the ARK Innovation ETF (ARKK) underperformed the broad-based indexes during the quarter. Among its top detractors were Roku (ROKU) and Zoom Video Communications (ZM). Shares of Roku detracted from performance for reasons discussed above. Zoom surpassed consensus expectations for the fourth quarter but disappointed on guidance. ARK retains high conviction in Zoom’s leadership in the video communications space with increased penetration in the enterprise as companies shift increasingly and permanently to hybrid work.  

Among the top contributors to ARKK’s performance were Tesla (TSLA) and Signify Health (SGFY), for reasons discussed above.

The 3D Printing ETF (PRNT), ARK Israel Innovation Technology ETF (IZRL), and ARK Transparency ETF (CTRU)

ARK’s self-indexed ETFs, The 3D Printing ETF (PRNT), ARK Israel Innovation Technology ETF (IZRL), and ARK Transparency ETF (CTRU), depreciated and underperformed the broad-based indexes during the quarter. Performance against their respective benchmarks was mixed, with IZRL and CTRU underperforming and PRNT outperforming. Shares of BICO Group (BICO), a producer of bio-inks and bioprinters, were the largest detractor from PRNT’s performance, as supply chain issues and other market forces prevailed. Velo3D (VLD) was the top contributor to PRNT’s performance after the company surpassed fourth-quarter earnings expectations. Shares of Nayax Ltd (NYAX), a point-of-sale fintech company, traded down alongside the broader market and were the largest detractor from IZRL’s performance. Shares of Gamida Cell (GMDA) were the top contributor to IZRL’s performance, rallying after the company announced it began the rolling submission of a Biologics License Application for Omidubicel, a treatment for blood cancers requiring stem cell transplants. Roblox (RBLX) was the largest detractor from CTRU’s performance after the company reported disappointing fourth-quarter results based on back-to-school headwinds in the US and Europe. That said, the company has paid $500 million to its young developer community and continues to lower barriers to creation for developers and gamers with Roblox Studio. AeroVironment (AVAV) was the top contributor to performance in CTRU for reasons discussed above.

ARK’s statements are not an endorsement of any company or a recommendation to buy, sell or hold any security. ARK and its clients as well as its related persons may (but do not necessarily) have financial interests in securities or issuers that are discussed. Certain of the statements contained may be statements of future expectations and other forward-looking statements that are based on ARK’s current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance, or events to differ materially from those expressed or implied in such statements.

Explore ARK Funds

Featured Funds:


ARK Autonomous Tech. & Robotics ETF


ARK Next Generation Internet ETF


ARK Genomic Revolution ETF


ARK Innovation ETF


The 3D Printing ETF


ARK Israel Innovative Technology ETF


ARK Fintech Innovation ETF


ARK Space Exploration & Innovation ETF

See All

ARK Trade Notifications

ARK offers fully transparent Exchange Traded Funds (“ETFs”) and provides investors with trade information for all actively managed ETFs.